Ascendis Pharma AS (ASND) — Capital Reinvestment Ratio

Latest as of December 2025: 0.05x

Ascendis Pharma AS (ASND) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow ($70.67 Million) in capital expenditures ($3.30 Million). See Ascendis Pharma AS (ASND) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

$70.67 Million
USD

Capital Expenditures

$3.30 Million
USD

Data as of

Dec 2025
Most recent filing

Ascendis Pharma AS Capital Reinvestment Ratio (2013–2025)

This chart tracks Ascendis Pharma AS's Capital Reinvestment Ratio across 2 annual periods. Check ASND cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Ascendis Pharma AS (2013–2025)

Year-by-year Capital Reinvestment Ratio for Ascendis Pharma AS from 2013 to 2025. For live market cap and broader valuation context, see Ascendis Pharma AS market cap and net worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.16x $51.77 Million $8.15 Million ▼ -16.9%
2013 0.19x $6.31 Million $1.20 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow